14 May 2025
WuXi Biologics Sells Leverkusen Plant to Terumo
The Leverkusen plant sale aligns with WuXi's strategy to focus on large-scale DP manufacturing in Singapore, enhancing global client solutions and optimizing asset returns. Completion expected in 2025.
